标题
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-12-04
DOI
10.3389/fnagi.2017.00394
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
- (2017) Lori N. Eidson et al. Journal of Neuroinflammation
- Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects
- (2017) D. Santos García et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
- (2017) Roberta Balestrino et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Parkinson Disease and Melanoma
- (2017) Lauren A. Dalvin et al. MAYO CLINIC PROCEEDINGS
- Increased risk of Parkinson disease with diabetes mellitus in a population-based study
- (2017) Yu-Wan Yang et al. MEDICINE
- Precision medicine for disease modification in Parkinson disease
- (2017) Alberto J. Espay et al. Nature Reviews Neurology
- Non-motor features of Parkinson disease
- (2017) Anthony H. V. Schapira et al. NATURE REVIEWS NEUROSCIENCE
- Cognitive and behavioral disorders in Parkinson’s disease: an update. II: behavioral disorders
- (2017) Luigi Trojano et al. NEUROLOGICAL SCIENCES
- Cognitive and behavioral disorders in Parkinson’s disease: an update. I: cognitive impairments
- (2017) Costanza Papagno et al. NEUROLOGICAL SCIENCES
- Vagotomy and Parkinson disease
- (2017) Bojing Liu et al. NEUROLOGY
- Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO-releasing neural precursors
- (2017) Stephana Carelli et al. NEUROPHARMACOLOGY
- Association of low serum BDNF with depression in patients with Parkinson's disease
- (2017) Yu Wang et al. PARKINSONISM & RELATED DISORDERS
- Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson’s disease
- (2017) Holly Green et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson’ Disease
- (2017) Jose A. Santiago et al. Frontiers in Aging Neuroscience
- Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology
- (2017) Jose A. Santiago et al. Frontiers in Aging Neuroscience
- Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1
- (2017) Robert A. Hauser et al. Journal of Parkinsons Disease
- Is Exenatide a Treatment for Parkinson’s Disease?
- (2017) Dilan Athauda et al. Journal of Parkinsons Disease
- Parkinson Disease and Autoimmune Disorders—What Can We Learn From Genome-wide Pleiotropy?
- (2017) Nikolaus R. McFarland et al. JAMA Neurology
- Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis
- (2017) Yongxing Gong et al. NEOPLASIA
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Red hair,MC1Rvariants, and risk for Parkinson's disease - a meta-analysis
- (2017) Xiqun Chen et al. Annals of Clinical and Translational Neurology
- Depression and Cognitive Impairment in Parkinson's Disease: A Role for Inflammation and Immunomodulation?
- (2017) Natália Pessoa Rocha et al. NEUROIMMUNOMODULATION
- Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters
- (2017) Ying-Shan Piao et al. Scientific Reports
- Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression
- (2016) Jan Fawcett et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cutaneous malignant melanoma and Parkinson disease: Common pathways?
- (2016) Rivka Inzelberg et al. ANNALS OF NEUROLOGY
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- Neuropsychiatric Issues in Parkinson’s Disease
- (2016) Jeffrey W. Cooney et al. Current Neurology and Neuroscience Reports
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Risk of Parkinson Disease in Diabetes Mellitus
- (2016) Xuejing Yue et al. MEDICINE
- NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity
- (2016) XIAO-DONG ZOU et al. Molecular Medicine Reports
- Direct α-synuclein promoter transactivation by the tumor suppressor p53
- (2016) Eric Duplan et al. Molecular Neurodegeneration
- MC1R variants in Chinese Han patients with sporadic Parkinson's disease
- (2016) Chang-he Shi et al. NEUROBIOLOGY OF AGING
- Increased Odds of Melanoma: Parkinson's Disease, Essential Tremor, Dystonia versus Controls
- (2016) Sherif Y. Shalaby et al. NEUROEPIDEMIOLOGY
- Pathophysiology underlying drooling in Parkinson’s disease: oropharyngeal bradykinesia
- (2016) Mehmet Karakoc et al. NEUROLOGICAL SCIENCES
- Association of AKT1 gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population
- (2016) Xiao-Yuan Li et al. NEUROSCIENCE LETTERS
- Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study
- (2016) Chava Peretz et al. PARKINSONISM & RELATED DISORDERS
- The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis
- (2016) Rong Ye et al. PLoS One
- Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology
- (2016) A. Elbaz REVUE NEUROLOGIQUE
- Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
- (2016) Jose A. Santiago et al. Scientific Reports
- Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
- (2016) Fernando Pagan et al. Journal of Parkinsons Disease
- Eryptosis as a marker of Parkinson's disease
- (2016) Etheresia Pretorius et al. Aging-US
- Iron and Oxidative Stress in Parkinson’s Disease: An Observational Study of Injury Biomarkers
- (2016) Marcio S. Medeiros et al. PLoS One
- Newly Diagnosed Anemia Increases Risk of Parkinson’s disease: A Population-Based Cohort Study
- (2016) Chien Tai Hong et al. Scientific Reports
- Increased risk of brain tumor in patients with Parkinson's disease: a nationwide cohort study in Taiwan
- (2015) C.-F. Tang et al. ACTA NEUROLOGICA SCANDINAVICA
- Risk of developing Parkinson's disease among patients with asthma: a nationwide longitudinal study
- (2015) C.-M. Cheng et al. ALLERGY
- TheMC1Rmelanoma risk variant p.R160W is associated with Parkinson disease
- (2015) Gemma Tell-Marti et al. ANNALS OF NEUROLOGY
- Vagotomy and subsequent risk of Parkinson's disease
- (2015) Elisabeth Svensson et al. ANNALS OF NEUROLOGY
- Investigation of Urination Disorder in Parkinson′s disease
- (2015) Li-Mei Zhang et al. CHINESE MEDICAL JOURNAL
- Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer
- (2015) Wen-han Li et al. DISEASE MARKERS
- The relevance of pre-motor symptoms in Parkinson’s disease
- (2015) Naomi Visanji et al. Expert Review of Neurotherapeutics
- MDDScore
- (2015) John A. Bilello et al. JOURNAL OF CLINICAL PSYCHIATRY
- PARKINInactivation Links Parkinson’s Disease to Melanoma
- (2015) Hui-Han Hu et al. JNCI-Journal of the National Cancer Institute
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- The Neuroprotective Effect of Erythropoietin on Rotenone-Induced Neurotoxicity in SH-SY5Y Cells Through the Induction of Autophagy
- (2015) Wooyoung Jang et al. MOLECULAR NEUROBIOLOGY
- Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression
- (2015) J C Felger et al. MOLECULAR PSYCHIATRY
- Nonmotor Symptoms in Subjects Without Evidence of Dopaminergic Deficits
- (2015) Fabienne S. Sprenger et al. MOVEMENT DISORDERS
- Laying the foundations for disease-modifying therapies in PD
- (2015) Patrik Brundin et al. Nature Reviews Neurology
- Depression—risk factor or early symptom in Parkinson disease?
- (2015) Albert F. Leentjens Nature Reviews Neurology
- Depression and subsequent risk of Parkinson disease: A nationwide cohort study
- (2015) H. Gustafsson et al. NEUROLOGY
- On the relationship between side of onset and cognition in Parkinson disease
- (2015) Roberto Erro et al. PARKINSONISM & RELATED DISORDERS
- Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type-B inhibitor: A Cross-Sectional, Cohort Study
- (2015) Khashayar Dashtipour et al. PHARMACOTHERAPY
- Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease
- (2015) Jose A. Santiago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson’s disease
- (2015) Harriet Keane et al. Scientific Reports
- Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
- (2015) Kyle Farmer et al. Frontiers in Aging Neuroscience
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- The relevance of pre-motor symptoms in Parkinson’s disease
- (2015) Naomi Visanji et al. Expert Review of Neurotherapeutics
- Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson Disease
- (2015) Ilir Agalliu et al. JAMA Neurology
- Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis
- (2015) Marianthi-Anna Kioumourtzoglou et al. JAMA Neurology
- PARKINInactivation Links Parkinson’s Disease to Melanoma
- (2015) Hui-Han Hu et al. JNCI-Journal of the National Cancer Institute
- Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
- (2015) Paola Bossù et al. Frontiers in Immunology
- Association Between Parkinson Disease and Risk of Cancer in Taiwan
- (2015) Pei-Ying Lin et al. JAMA Oncology
- The associations between Parkinson’s disease and cancer: the plot thickens
- (2015) Danielle D. Feng et al. Translational Neurodegeneration
- Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
- (2015) Jose A. Santiago et al. PLoS One
- Nonmotor Symptoms and Cognitive Decline in de novo Parkinson’s Disease
- (2014) Kyum-Yil Kwon et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Differential risks of cancer types in people with Parkinson’s disease: A national record-linkage study
- (2014) E.L. Ong et al. EUROPEAN JOURNAL OF CANCER
- c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
- (2014) Anne-Laure Mahul-Mellier et al. HUMAN MOLECULAR GENETICS
- The early course of affective and cognitive symptoms in de novo patients with Parkinson’s disease
- (2014) Gianfranco Spalletta et al. JOURNAL OF NEUROLOGY
- Association between 5-HTTLPR polymorphism and Parkinson’s disease: a meta analysis
- (2014) Lianbo Gao et al. MOLECULAR BIOLOGY REPORTS
- An anemia of Alzheimer's disease
- (2014) N G Faux et al. MOLECULAR PSYCHIATRY
- Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
- (2014) Daniela Berg et al. MOVEMENT DISORDERS
- Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
- (2014) Yongxing Gong et al. NATURE GENETICS
- System-based approaches to decode the molecular links in Parkinson's disease and diabetes
- (2014) Jose A. Santiago et al. NEUROBIOLOGY OF DISEASE
- Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS
- (2014) Jennifer G. Goldman et al. PARKINSONISM & RELATED DISORDERS
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
- (2014) Lin Lu et al. PLoS One
- Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
- (2014) Jose A. Santiago et al. PLoS One
- Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies
- (2014) Ferrán Catalá-López et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- A network approach to clinical intervention in neurodegenerative diseases
- (2014) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
- (2014) Senthilkumar S. Karuppagounder et al. Scientific Reports
- The emerging role of nutrition in Parkinson's disease
- (2014) Stacey E. Seidl et al. Frontiers in Aging Neuroscience
- Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy
- (2014) E E Redei et al. Translational Psychiatry
- Parkinson's Disease and Cancer: A Register-based Family Study
- (2013) K. Wirdefeldt et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients
- (2013) Takahiko Kawate et al. BREAST CANCER RESEARCH AND TREATMENT
- Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
- (2013) Nicole Bethge et al. Epigenetics
- Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti-parkinson agents
- (2013) Li Gao et al. FEBS Journal
- High-expression of DJ-1 and Loss of PTEN Associated with Tumor Metastasis and Correlated with Poor Prognosis of Gastric Carcinoma
- (2013) Yin Li et al. International Journal of Medical Sciences
- Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease
- (2013) Wooyoung Jang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial
- (2013) Radu Constantinescu et al. MOVEMENT DISORDERS
- Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations inLRRK2
- (2013) Javier Ruiz-Martínez et al. MOVEMENT DISORDERS
- Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin
- (2013) Shannon L. Rhodes et al. NEUROBIOLOGY OF DISEASE
- Risk of Parkinson disease after depression: A nationwide population-based study
- (2013) C.-C. Shen et al. NEUROLOGY
- Diabetes is associated with postural instability and gait difficulty in Parkinson disease
- (2013) Vikas Kotagal et al. PARKINSONISM & RELATED DISORDERS
- Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity
- (2013) Antonio Ciaramella et al. PLoS One
- Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
- (2013) Jose A. Santiago et al. PLoS One
- Shared dysregulated pathways lead to Parkinson's disease and diabetes
- (2013) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses
- (2013) Gianfranco Spalletta et al. Neuropsychiatric Disease and Treatment
- Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases
- (2013) S. Mariani et al. Frontiers in Aging Neuroscience
- Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
- (2013) Irene Pichler et al. PLOS MEDICINE
- Shared Predispositions of Parkinsonism and Cancer
- (2012) Seth A. Kareus et al. ARCHIVES OF NEUROLOGY
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Risk of Parkinson Disease Onset in Patients With Diabetes: A 9-year population-based cohort study with age and sex stratifications
- (2012) Y. Sun et al. DIABETES CARE
- Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease
- (2012) Kathrine Rugbjerg et al. INTERNATIONAL JOURNAL OF CANCER
- Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
- (2012) Domenico Bosco et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease
- (2012) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Serum Iron, Vitamin B12 and Folic Acid Levels in Parkinson’s Disease
- (2012) Gulizar Madenci et al. NEUROCHEMICAL RESEARCH
- The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
- (2012) R. Inzelberg et al. NEUROLOGY
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
- (2012) Tianhong Pan et al. PLoS One
- Hallucinations in Neurodegenerative Diseases
- (2011) Lothar Burghaus et al. CNS Neuroscience & Therapeutics
- Diabetes and the Risk of Developing Parkinson's Disease in Denmark
- (2011) E. Schernhammer et al. DIABETES CARE
- Diabetes and Risk of Parkinson's Disease
- (2011) Q. Xu et al. DIABETES CARE
- Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer
- (2011) Hua-Zong Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer
- (2011) Xiang Yi HE et al. Journal of Digestive Diseases
- Endocrine disruptors in the etiology of type 2 diabetes mellitus
- (2011) Paloma Alonso-Magdalena et al. Nature Reviews Endocrinology
- Depression in Parkinson disease—epidemiology, mechanisms and management
- (2011) Dag Aarsland et al. Nature Reviews Neurology
- Meta-analysis of the relationship between Parkinson disease and melanoma
- (2011) R. Liu et al. NEUROLOGY
- Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
- (2011) B. D. Looyenga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study
- (2010) F. M. Nilsson et al. ACTA PSYCHIATRICA SCANDINAVICA
- Metal Emissions and Urban Incident Parkinson Disease: A Community Health Study of Medicare Beneficiaries by Using Geographic Information Systems
- (2010) A. W. Willis et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- α-Synuclein binds the KATP channel at insulin-secretory granules and inhibits insulin secretion
- (2010) Xuehui Geng et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Increased Melanoma Risk in Parkinson Disease
- (2010) John M. Bertoni ARCHIVES OF NEUROLOGY
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
- (2010) Kawser Akter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Parkinson’s disease and cancer risk: a systematic review and meta-analysis
- (2010) Archna Bajaj et al. CANCER CAUSES & CONTROL
- PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells☆
- (2010) Arnaud Berthier et al. HUMAN PATHOLOGY
- Response and remission criteria in major depression – A validation of current practice
- (2010) Michael Riedel et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Skin cancer and Parkinson's disease
- (2010) Joaquim J. Ferreira et al. MOVEMENT DISORDERS
- Comorbid cancer in Parkinson's disease
- (2010) Raymond Y. Lo et al. MOVEMENT DISORDERS
- What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
- (2010) David A. Gallagher et al. MOVEMENT DISORDERS
- Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study
- (2010) Fang Fang et al. MOVEMENT DISORDERS
- Occurrence of depression and anxiety prior to Parkinson’s disease
- (2010) E.L. Jacob et al. PARKINSONISM & RELATED DISORDERS
- LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
- (2010) Soreya Belarbi et al. PARKINSONISM & RELATED DISORDERS
- Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
- (2010) Yasuhiro Matsuo et al. PLoS One
- α-Synuclein and dopamine at the crossroads of Parkinson's disease
- (2010) Lara Lourenço Venda et al. TRENDS IN NEUROSCIENCES
- Heavy metals, islet function and diabetes development
- (2010) Ya Wen Chen et al. Islets
- Genetic determinants of hair color and parkinson's disease risk
- (2009) Xiang Gao et al. ANNALS OF NEUROLOGY
- A clinico-pathological study of subtypes in Parkinson's disease
- (2009) M. Selikhova et al. BRAIN
- The particular relationship between Parkinson’s disease and malignancy: a focus on skin cancers
- (2009) Rivka Inzelberg et al. JOURNAL OF NEURAL TRANSMISSION
- Non-motor symptoms in Parkinson’s disease
- (2009) Ariane Park et al. JOURNAL OF NEUROLOGY
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study
- (2009) R. Savica et al. NEUROLOGY
- Family history of melanoma and Parkinson disease risk
- (2009) X. Gao et al. NEUROLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Restless Legs Syndrome
- (2008) Pankaj Satija et al. CNS DRUGS
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
- (2008) J. A. Driver et al. DIABETES CARE
- Association between AKT1 gene and Parkinson's disease: A protective haplotype
- (2008) Georgia Xiromerisiou et al. NEUROSCIENCE LETTERS
- Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review
- (2008) Ruth Peters et al. BMC Geriatrics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now